3-氯-1-甲氧基丙-1-烯 | 80986-54-5

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机氯化物
• 中文名称: 3-氯-1-甲氧基丙-1-烯
• 英文名称: 3-methoxyallyl chloride
• 英文别名: 3-Chloro-1-methoxyprop-1-ene
• CAS: 80986-54-5
• 化学式: C₄H₇ClO
• mdl: MFCD24394133
• 分子量: 106.552
• InChiKey: JDKKBMPFXNGAEQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  6
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-异丙基苯甲酸 、 3-氯-1-甲氧基丙-1-烯 在 正丁基锂 、 二氧化碳 、 溴 、 二异丙胺 作用下， 生成 4-(4-Bromo-2-methyl-5-oxopentan-2-yl)benzoic acid
  参考文献：
  名称：

  10-烷基-10-去氮杂蝶呤的合成和抗肿瘤活性。一种方便的10-脱氮蝶呤合成方法。

  摘要：

  大规模合成有效的抗肿瘤药10-脱氮蝶呤的要求导致了该化合物及其10-烷基类似物的简便合成的发展。用3-甲氧基烯丙基氯将适当的对烷基苯甲酸的二异丙基氨基锂锂生成的二价阴离子烷基化。在pH 7-8下将所得的4-（对羧基苯基）-1-甲氧基-1-丁烯溴化，得到2-溴-4-（对羧基苯基）丁醛。与2,4,5,6-四氨基嘧啶缩合，然后原位氧化所得的二蝶啶，得到结晶的10-烷基-10-脱氮基-4-氨基-4-脱氧蝶酸。通过混合酸酐法将蝶酸与谷氨酸二乙酯偶联，然后在室温下皂化，以得到目标10-脱氮蝶呤类化合物。10-烷基化合物作为叶酸依赖性细菌的生长抑制剂与10-脱氮蝶呤大致相等。它们抑制干酪乳杆菌和L1210衍生的二氢叶酸还原酶的能力也相似。体外转运特性提示10-烷基类似物的治疗指数得到改善。相对于小鼠中的L1210，在LD10剂量下，寿命延长百分比为+ 151％（甲氨蝶呤），+ 178％（10-脱氮蝶呤），+

  DOI：

  10.1021/jm00352a026
• 作为产物：
  描述：

  1-甲氧基-1,2-丙二烯 在 盐酸 作用下， 以 乙醚 为溶剂， 反应 0.5h， 生成 3-氯-1-甲氧基丙-1-烯
  参考文献：
  名称：

  Analogues of the Potent Nonpolyglutamatable Antifolate N^α-(4-Amino-4-deoxypteroyl)-N^δ-hemiphthaloyl-l-ornithine (PT523) with Modifications in the Side Chain, p-Aminobenzoyl Moiety, or 9,10-Bridge:  Synthesis and in Vitro Antitumor Activity

  摘要：

  Seven N-alpha-(4-amino-4-deoxypteroyl)-N-sigma-hemiphtha (2, PT523) analogues were synthesized by modifications of the literature synthesis of the corresponding AMT (1) analogues and were tested as inhibitors of tumor cell growth. in growth assays against cultured CCRF-CEM human leukemic cells exposed to drug for 72 h, the IC50 values of analogues in which N-10 was replaced by CH2 and CHMe were found to be 0.55 +/- 0.07 and 0.63 +/- 0.08 nM, and thus these analogues are more potent than 1 (IC50 = 4.4 +/- 1.0 nM) or 2 (IC50 = 1.5 +/-: 0.39 nM). The 10-ethyl-10-deaza analogue of 2 (IC50 = 1.2 +/- 0.25 nM) was not statistically different from 2 but was more potent than edatrexate, the 10-ethyl-10-deaza analogue of 1, which had an IC50 of 3.3 +/- 0.36 nM. In contrast, the analogue of 2 with both an ethyl and a CO2Me group at the 10-position had an IC50 of 54 +/- 4.9 nM, showing this modification to be unfavorable. The 4-amino-1-naphthoic acid analogue of 2 had an IC50 Of 1.2 +/- 0.22 nM, indicating that replacement of the p-aminobenzoic acid (pABA) moiety does not diminish cytotoxicity. The analogues in which the (CH2)(3) Side chain was replaced by slightly longer CH2SCH2 and (CH2)(2)-SCH2 groups gave IC50 values of 4.4 +/- 1.1 and 5.0 +/- 0.56 nM and thus were somewhat less potent than the parent molecule. However the analogues in which the aromatic COOH group was at the meta and para positions of the phthaloyl ring had IC50 values of 7.5 +/- 0.47 and 55 +/- 0.07 nM, confirming the low potency we had previously observed with these compounds against other cell lines. Overall, the results in this study support the conclusion that, while the position of the phthaloyl COOH group and the length of the amino acid side chain in 2 are important determinants of cytotoxic potency, changes in the pABA region and 9,10-bridge are well-tolerated and can even increase potency.

  DOI：

  10.1021/jm990630f

文献信息

• Synthesis and antifolate properties of 10-alkyl-5,10-dideaza analogs of methotrexate and tetrahydrofolic acid
  作者：Joseph I. DeGraw、Pamela H. Christie、Roy L. Kisliuk、Yvette Gaumont、Francis M. Sirotnak

  DOI：10.1021/jm00164a033

  日期：1990.2

  10-dideazapteroic acids (7a,b). Coupling with diethyl glutamate followed by ester hydrolysis afforded 10-alkyl-5,10-dideazaminopterin analogues 9a,b. Hydrolysis of the 4-amino group of 7a,b yielded the 10-alkylpteroic acids, which were coupled with diethyl glutamate, hydrogenated over PtO2, and saponified to afford 10-alkyl-5,10-dideazatetrahydrofolic acids 13a,b. Aminopterin analogues 9a,b were effective

  据报道，合成了5,10-二叠氮基氢叶酸（DDTHF）的10-甲基和10-乙基类似物，这是一种有效的甘氨酰胺核糖核苷酸（GAR）甲酰基转移酶抑制剂。该过程中的关键中间体是10-甲基-和10-乙基-4-氨基-4-脱氧-5,10-二叠氮基壬酸。支化的4-（对-甲氧基甲氧基苯基）丁醛的哌啶烯胺与（乙酰氧基亚甲基）丙二腈的缩合得到1，1-二氰基-4-哌啶子基丁二烯5a，b。随后与醇性氢氧化铵反应，得到适当取代的2-氨基-3-氰基吡啶6a，b。用胍闭环得到10-甲基-和10-乙基-4-氨基-4-脱氧-5,10-二脱氮杂戊酸（7a，b）。与谷氨酸二乙酯偶联，然后进行酯水解，得到10，烷基-5，10-二脱氮氨基蝶呤类似物9a，b。7a的4-氨基水解 b得到10-烷基蝶酸，将其与谷氨酸二乙酯偶联，经PtO 2氢化，并皂化得到10-烷基-5，10-二叠氮基四氢叶酸13a，b。氨基蝶呤类似物9a，b是源自L12
• Synthesis of 5,10-dideazaminopterin
  作者：Joseph I. Degraw、Hiroaki Tagawa、Pamela H. Christie、John A. Lawson、Edward G. Brown、Roy L. Kisliuk、Yvette Gaumont

  DOI：10.1002/jhet.5570230101

  日期：1986.1

  The synthesis of 5,10-dideazaaminopterin by two independent routes is described. Condensation of the piperidine enamine of 4-p-carbomethoxyphenylbutyraldehyde (4) with ethoxymethylenemalononitrile followed by treatment of the resultant arylethylenaminomalononitrile (5) with methanolic ammonia produced 2-amino-3-cyano-5-p-carbomethoxyphenethylpyridine (6). Cyclization of the aminocyanopyridine with

  描述了通过两个独立的途径合成5,10-二氮杂氨基蝶呤。4-对-甲氧基甲氧基苯基丁醛的哌啶烯胺（4）与乙氧基亚甲基丙二腈的缩合，然后用甲醇氨处理所得的芳基乙烯基丙二腈（5），产生2-氨基-3-氰基-5-对-甲氧基甲氧基苯乙基吡啶（6）。用胍将氨基氰基吡啶环化，得到4-氨基-4-脱氧-5,10-二脱氮杂戊酸（8）。蝶呤中间体与谷氨酸的偶联产生目标5,10-二氮杂min蝶呤（10）。
• Heteroatom-directed allylic substitution and rearrangement reactions
  作者：James P. Hagen、Joseph J. Harris、Danielle Lakin

  DOI：10.1021/jo00381a014

  日期：1987.3
• Synthesis and antitumor activity of 10-alkyl-10-deazaminopterins. A convenient synthesis of 10-deazaminopterin
  作者：J. I. DeGraw、V. H. Brown、H. Tagawa、R. L. Kisliuk、Y. Gaumont、F. M. Sirotnak

  DOI：10.1021/jm00352a026

  日期：1982.10

  Requirements for large-scale synthesis of the potent antitumor drug 10-deazaminopterin have led to development of a facile synthesis of this compound and its 10-alkyl analogues. The lithium diisopropyl amide generated dianions of appropriate p-alkylbenzoic acids were alkylated with 3-methoxyallyl chloride. The resulting 4-(p-carboxyphenyl)-1-methoxy-1-butenes were brominated at pH 7-8 to afford the

  大规模合成有效的抗肿瘤药10-脱氮蝶呤的要求导致了该化合物及其10-烷基类似物的简便合成的发展。用3-甲氧基烯丙基氯将适当的对烷基苯甲酸的二异丙基氨基锂锂生成的二价阴离子烷基化。在pH 7-8下将所得的4-（对羧基苯基）-1-甲氧基-1-丁烯溴化，得到2-溴-4-（对羧基苯基）丁醛。与2,4,5,6-四氨基嘧啶缩合，然后原位氧化所得的二蝶啶，得到结晶的10-烷基-10-脱氮基-4-氨基-4-脱氧蝶酸。通过混合酸酐法将蝶酸与谷氨酸二乙酯偶联，然后在室温下皂化，以得到目标10-脱氮蝶呤类化合物。10-烷基化合物作为叶酸依赖性细菌的生长抑制剂与10-脱氮蝶呤大致相等。它们抑制干酪乳杆菌和L1210衍生的二氢叶酸还原酶的能力也相似。体外转运特性提示10-烷基类似物的治疗指数得到改善。相对于小鼠中的L1210，在LD10剂量下，寿命延长百分比为+ 151％（甲氨蝶呤），+ 178％（10-脱氮蝶呤），+
• Analogues of the Potent Nonpolyglutamatable Antifolate <i>N</i>^α-(4-Amino-4-deoxypteroyl)-<i>N</i>^δ-hemiphthaloyl-<scp>l</scp>-ornithine (PT523) with Modifications in the Side Chain, <i>p</i>-Aminobenzoyl Moiety, or 9,10-Bridge:  Synthesis and in Vitro Antitumor Activity
  作者：Andre Rosowsky、Joel E. Wright、Chitra M. Vaidya、Ronald A. Forsch、Henry Bader

  DOI：10.1021/jm990630f

  日期：2000.4.1

  Seven N-alpha-(4-amino-4-deoxypteroyl)-N-sigma-hemiphtha (2, PT523) analogues were synthesized by modifications of the literature synthesis of the corresponding AMT (1) analogues and were tested as inhibitors of tumor cell growth. in growth assays against cultured CCRF-CEM human leukemic cells exposed to drug for 72 h, the IC50 values of analogues in which N-10 was replaced by CH2 and CHMe were found to be 0.55 +/- 0.07 and 0.63 +/- 0.08 nM, and thus these analogues are more potent than 1 (IC50 = 4.4 +/- 1.0 nM) or 2 (IC50 = 1.5 +/-: 0.39 nM). The 10-ethyl-10-deaza analogue of 2 (IC50 = 1.2 +/- 0.25 nM) was not statistically different from 2 but was more potent than edatrexate, the 10-ethyl-10-deaza analogue of 1, which had an IC50 of 3.3 +/- 0.36 nM. In contrast, the analogue of 2 with both an ethyl and a CO2Me group at the 10-position had an IC50 of 54 +/- 4.9 nM, showing this modification to be unfavorable. The 4-amino-1-naphthoic acid analogue of 2 had an IC50 Of 1.2 +/- 0.22 nM, indicating that replacement of the p-aminobenzoic acid (pABA) moiety does not diminish cytotoxicity. The analogues in which the (CH2)(3) Side chain was replaced by slightly longer CH2SCH2 and (CH2)(2)-SCH2 groups gave IC50 values of 4.4 +/- 1.1 and 5.0 +/- 0.56 nM and thus were somewhat less potent than the parent molecule. However the analogues in which the aromatic COOH group was at the meta and para positions of the phthaloyl ring had IC50 values of 7.5 +/- 0.47 and 55 +/- 0.07 nM, confirming the low potency we had previously observed with these compounds against other cell lines. Overall, the results in this study support the conclusion that, while the position of the phthaloyl COOH group and the length of the amino acid side chain in 2 are important determinants of cytotoxic potency, changes in the pABA region and 9,10-bridge are well-tolerated and can even increase potency.